Edition:
United States

Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

42.80USD
23 May 2018
Change (% chg)

$0.59 (+1.40%)
Prev Close
$42.21
Open
$41.88
Day's High
$42.82
Day's Low
$41.88
Volume
65,392
Avg. Vol
108,206
52-wk High
$46.81
52-wk Low
$29.58

Chart for

About

Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $1,667.74
Shares Outstanding(Mil.): 43.51
Dividend: --
Yield (%): --

Financials

  RGEN.OQ Industry Sector
P/E (TTM): 75.20 30.95 32.75
EPS (TTM): 0.51 -- --
ROI: 6.40 14.84 14.38
ROE: 9.98 16.34 16.07

BRIEF-Repligen Reports Q1 Adjusted Non-GAAP Earnings Per Share Of $0.17

* Q1 EARNINGS PER SHARE VIEW $0.15 -- THOMSON REUTERS I/B/E/S

May 08 2018

BRIEF-Repligen Reports Q4 GAAP Earnings Per Share $0.27

* REPLIGEN REPORTS FOURTH QUARTER 2017 FINANCIAL RESULTS, PROVIDES GUIDANCE FOR 2018

Feb 22 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $123.45 +0.54
Novartis AG (NOVN.S) CHF76.16 -0.52
Roche Holding Ltd. (ROG.S) CHF219.25 -4.65
Roche Holding Ltd. (RO.S) CHF223.40 -5.40
Merck & Co., Inc. (MRK.N) $59.17 +0.72
Sanofi SA (SASY.PA) €66.23 -0.14
Amgen, Inc. (AMGN.OQ) $179.94 +1.58
Gilead Sciences, Inc. (GILD.OQ) $68.17 +0.34
Incyte Corporation (INCY.OQ) $66.57 +0.01

Earnings vs. Estimates